R Senior1, A Lahiri. 1. Northwick Park Hospital, Watford Road, Harrow, Middlesex HA1 3UJ, UK.
Abstract
OBJECTIVE: To evaluate whether the predictive value of dobutamine echocardiography for assessing contractile reserve was altered by differing patterns of regional myocardial perfusion. PATIENTS: 31 consecutive patients with symptomatic congestive heart failure (left ventricular ejection fraction < 35%) caused by coronary artery disease. SETTING: A district general hospital. METHODS: Thallium-201 perfusion imaging and low dose dobutamine (5-15 microg/kg/min) echocardiography were performed and resting echocardiography was repeated three months after revascularisation. Perfusion pattern and systolic wall thickening were compared using a 12 segment left ventricular model. RESULTS: Of the 273 severely dysfunctional segments, 106 (39%) showed a normal perfusion and 167 (61%) an abnormal pattern. After revascularisation, recovery occurred in 71 of the segments with a normal perfusion pattern, and in these a dobutamine response was observed in 61 (86%); recovery also occurred in 56 segments with a mild to moderate abnormality of perfusion, and in these a dobutamine response was seen in 46 (81%) (NS). After revascularisation, the positive and negative predictive values for recovery of dysfunctional segments, where the majority were abnormally perfused, were 88% and 86%, respectively. Systolic wall thickening score indices improved from (mean (SD)) 3.21 (0.58) to 2. 6 (0.66) (p < 0.001) after revascularisation in dobutamine responsive patients (n = 24) compared with patients who did not show a dobutamine response (2.86 (0.65) and 3.13 (0.56), p = 0.61, respectively). CONCLUSIONS: Dobutamine echocardiography predicted improvement of dysfunctional myocardium after revascularisation irrespective of the resting perfusion pattern seen.
OBJECTIVE: To evaluate whether the predictive value of dobutamine echocardiography for assessing contractile reserve was altered by differing patterns of regional myocardial perfusion. PATIENTS: 31 consecutive patients with symptomatic congestive heart failure (left ventricular ejection fraction < 35%) caused by coronary artery disease. SETTING: A district general hospital. METHODS:Thallium-201 perfusion imaging and low dose dobutamine (5-15 microg/kg/min) echocardiography were performed and resting echocardiography was repeated three months after revascularisation. Perfusion pattern and systolic wall thickening were compared using a 12 segment left ventricular model. RESULTS: Of the 273 severely dysfunctional segments, 106 (39%) showed a normal perfusion and 167 (61%) an abnormal pattern. After revascularisation, recovery occurred in 71 of the segments with a normal perfusion pattern, and in these a dobutamine response was observed in 61 (86%); recovery also occurred in 56 segments with a mild to moderate abnormality of perfusion, and in these a dobutamine response was seen in 46 (81%) (NS). After revascularisation, the positive and negative predictive values for recovery of dysfunctional segments, where the majority were abnormally perfused, were 88% and 86%, respectively. Systolic wall thickening score indices improved from (mean (SD)) 3.21 (0.58) to 2. 6 (0.66) (p < 0.001) after revascularisation in dobutamine responsive patients (n = 24) compared with patients who did not show a dobutamine response (2.86 (0.65) and 3.13 (0.56), p = 0.61, respectively). CONCLUSIONS:Dobutamine echocardiography predicted improvement of dysfunctional myocardium after revascularisation irrespective of the resting perfusion pattern seen.
Authors: H Baumgartner; G Porenta; Y K Lau; M Wutte; U Klaar; M Mehrabi; R J Siegel; J Czernin; G Laufer; H Sochor; H Schelbert; M C Fishbein; G Maurer Journal: J Am Coll Cardiol Date: 1998-11-15 Impact factor: 24.094
Authors: K T Sun; J Czernin; J Krivokapich; Y K Lau; M Böttcher; G Maurer; M E Phelps; H R Schelbert Journal: Circulation Date: 1996-12-15 Impact factor: 29.690
Authors: S Sawada; G Elsner; D S Segar; M O'Shaughnessy; S Khouri; J Foltz; P D Bourdillon; J R Bates; N Fineberg; T Ryan; G D Hutchins; H Feigenbaum Journal: J Am Coll Cardiol Date: 1997-01 Impact factor: 24.094
Authors: J L Vanoverschelde; A M D'Hondt; T Marwick; B L Gerber; M De Kock; R Dion; W Wijns; J A Melin Journal: J Am Coll Cardiol Date: 1996-08 Impact factor: 24.094
Authors: R Senior; B Glenville; S Basu; B S Sridhara; E Anagnostou; R Stanbridge; S J Edmondson; C E Handler; E B Raftery; A Lahiri Journal: Br Heart J Date: 1995-10
Authors: T Zaglavara; R Haaverstad; B Cumberledge; T Irvine; H Karvounis; G Parharidis; G Louridas; A Kenny Journal: Heart Date: 2002-04 Impact factor: 5.994
Authors: H Yamagishi; K Akioka; K Hirata; Y Sakanoue; I Toda; M Yoshiyama; M Teragaki; K Takeuchi; J Yoshikawa; H Ochi Journal: J Nucl Cardiol Date: 2001 Jan-Feb Impact factor: 5.952
Authors: Michael Salerno; Laine Elliot; Linda K Shaw; Jonathan P Piccini; Robert Pagnanelli; Salvador Borges-Neto Journal: J Nucl Cardiol Date: 2009-06-03 Impact factor: 5.952
Authors: Ify R Mordi; Athar A Badar; R John Irving; Jonathan R Weir-McCall; J Graeme Houston; Chim C Lang Journal: Vasc Health Risk Manag Date: 2017-11-21